Anti-Inflammatory Activity of Soluble Epoxide Hydrolase Inhibitors Based on Selenoureas Bearing an Adamantane Moiety

Int J Mol Sci. 2022 Sep 14;23(18):10710. doi: 10.3390/ijms231810710.

Abstract

The inhibitory potency of the series of inhibitors of the soluble epoxide hydrolase (sEH) based on the selenourea moiety and containing adamantane and aromatic lipophilic groups ranges from 34.3 nM to 1.2 μM. The most active compound 5d possesses aliphatic spacers between the selenourea group and lipophilic fragments. Synthesized compounds were tested against the LPS-induced activation of primary murine macrophages. The most prominent anti-inflammatory activity, defined as a suppression of nitric oxide synthesis by LPS-stimulated macrophages, was demonstrated for compounds 4a and 5b. The cytotoxicity of the obtained substances was studied using human neuroblastoma and fibroblast cell cultures. Using these cell assays, the cytotoxic concentration for 4a was 4.7-18.4 times higher than the effective anti-inflammatory concentration. The genotoxicity and the ability to induce oxidative stress was studied using bacterial lux-biosensors. Substance 4a does not exhibit genotoxic properties, but it can cause oxidative stress at concentrations above 50 µM. Put together, the data showed the efficacy and safety of compound 4a.

Keywords: adamantane; anti-inflammatory; inhibitor; selenourea; soluble epoxide hydrolase.

MeSH terms

  • Adamantane* / pharmacology
  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Epoxide Hydrolases*
  • Humans
  • Lipopolysaccharides / pharmacology
  • Mice
  • Nitric Oxide
  • Organoselenium Compounds
  • Urea / analogs & derivatives

Substances

  • Anti-Inflammatory Agents
  • Enzyme Inhibitors
  • Lipopolysaccharides
  • Organoselenium Compounds
  • selenourea
  • Nitric Oxide
  • Urea
  • Epoxide Hydrolases
  • Adamantane